Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer
      QxMD      Google Scholar   
Citation:
JAMA
Year:
2024
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
13
Parents:
3708  
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
Bayer  
Grants:
U10CA180821, U10CA180882, UG1CA233180, UG1CA233196, UG1CA233329, UG1CA233373, U10CA180868 (NRG Oncology), U10CA180888 (SWOG).  
Corr. Author:
 
Authors:
                             
Networks:
LAPS-CT018, LAPS-IL057, LAPS-MA036, LAPS-MD017, LAPS-NC007, LAPS-TX035, ME040, NH038, NY167, PCRC, SCOR   
Study
Alliance-A011502
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: